share_log

Dutch Bros Inc. (NYSE:BROS) Receives Average Recommendation of "Moderate Buy" From Analysts

Defense World ·  Sep 26, 2022 02:11

Shares of Dutch Bros Inc. (NYSE:BROS – Get Rating) have been given an average rating of "Moderate Buy" by the eleven research firms that are presently covering the company, Marketbeat Ratings reports. Two analysts have rated the stock with a hold recommendation and four have assigned a buy recommendation to the company. The average 12-month price objective among brokers that have covered the stock in the last year is $49.40.

Several brokerages recently weighed in on BROS. Cowen boosted their target price on Dutch Bros to $53.00 in a research note on Monday, August 15th. Robert W. Baird boosted their price target on Dutch Bros from $30.00 to $46.00 in a research note on Thursday, August 11th. Piper Sandler boosted their price objective on Dutch Bros from $44.00 to $50.00 and gave the company an "overweight" rating in a report on Thursday, August 11th. Barclays boosted their price objective on Dutch Bros from $34.00 to $37.00 and gave the company an "equal weight" rating in a report on Thursday, August 11th. Finally, JPMorgan Chase & Co. cut Dutch Bros from an "overweight" rating to a "neutral" rating and set a $40.00 price target for the company. in a report on Wednesday, June 8th. They noted that the move was a valuation call.

Get Dutch Bros alerts:

Insiders Place Their Bets

In related news, CEO Joth Ricci sold 71,125 shares of the firm's stock in a transaction dated Monday, August 15th. The stock was sold at an average price of $46.30, for a total transaction of $3,293,087.50. Following the transaction, the chief executive officer now owns 2,453,865 shares of the company's stock, valued at $113,613,949.50. The transaction was disclosed in a filing with the SEC, which is accessible through this link. In related news, COO Brian Maxwell sold 48,000 shares of Dutch Bros stock in a transaction that occurred on Wednesday, August 3rd. The stock was sold at an average price of $40.12, for a total transaction of $1,925,760.00. Following the completion of the transaction, the chief operating officer now directly owns 1,171,620 shares in the company, valued at approximately $47,005,394.40. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Also, CEO Joth Ricci sold 71,125 shares of Dutch Bros stock in a transaction that occurred on Monday, August 15th. The stock was sold at an average price of $46.30, for a total value of $3,293,087.50. Following the transaction, the chief executive officer now owns 2,453,865 shares of the company's stock, valued at $113,613,949.50. The disclosure for this sale can be found here. Over the last 90 days, insiders have sold 210,125 shares of company stock valued at $9,392,648. 49.30% of the stock is currently owned by insiders.

Institutional Inflows and Outflows

Several institutional investors have recently bought and sold shares of BROS. Captrust Financial Advisors lifted its holdings in Dutch Bros by 87.9% in the 2nd quarter. Captrust Financial Advisors now owns 1,114 shares of the company's stock worth $35,000 after buying an additional 521 shares in the last quarter. Legal & General Group Plc acquired a new position in Dutch Bros in the 2nd quarter worth $174,000. Kingsview Wealth Management LLC acquired a new position in Dutch Bros in the 2nd quarter worth $423,000. Price T Rowe Associates Inc. MD lifted its holdings in Dutch Bros by 5.0% in the 2nd quarter. Price T Rowe Associates Inc. MD now owns 1,024,255 shares of the company's stock worth $32,418,000 after buying an additional 49,097 shares in the last quarter. Finally, Public Employees Retirement Association of Colorado acquired a new position in Dutch Bros in the 2nd quarter worth $4,662,000.

Dutch Bros Stock Down 5.8 %

Shares of BROS stock opened at $32.19 on Monday. Dutch Bros has a 1-year low of $20.05 and a 1-year high of $81.40. The stock's fifty day moving average price is $38.55 and its 200 day moving average price is $41.38. The company has a debt-to-equity ratio of 1.19, a current ratio of 0.54 and a quick ratio of 0.30. The company has a market cap of $1.27 billion and a price-to-earnings ratio of -97.54.

Dutch Bros (NYSE:BROS – Get Rating) last announced its earnings results on Wednesday, August 10th. The company reported $0.05 earnings per share for the quarter, missing the consensus estimate of $0.07 by ($0.02). Dutch Bros had a positive return on equity of 0.55% and a negative net margin of 2.54%. The business had revenue of $186.38 million for the quarter, compared to analysts' expectations of $182.56 million. The business's revenue for the quarter was up 44.2% on a year-over-year basis. On average, research analysts expect that Dutch Bros will post -0.04 earnings per share for the current fiscal year.

Dutch Bros Company Profile

(Get Rating)

Dutch Bros Inc operates and franchises drive-thru shops. It offers Dutch Bros hot and cold espresso-based beverages, and cold brew coffee products, as well as Blue Rebel energy drinks, tea, lemonade, smoothies, and other beverages through company-operated shops and online channels. As of May 11, 2022, it operated 572 drive-thru coffee locations across 12 states in the United States.

Featured Articles

  • Get a free copy of the StockNews.com research report on Dutch Bros (BROS)
  • Can Caterpillar Claw Higher in a Falling Market?
  • Is Dave & Buster's Immune to High Inflation and Lower Spending?
  • Should These 3 Top-Performing Mid-Caps Be On Your Watchlist?
  • Will Wall Street's Enthusiasm About Datadog Lead To Big Gains?
  • MarketBeat: Week in Review 9/19 – 9/23

Receive News & Ratings for Dutch Bros Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Dutch Bros and related companies with MarketBeat.com's FREE daily email newsletter.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment